Ranbaxy posts Rs 2,982 cr quarterly loss

Drug firm Ranbaxy Laboratories on Thursday said its consolidated net loss widened to Rs 2,982.7 crore in the fourth quarter ended December 31, 2011, over the same period previous year.

The company had posted a net loss (after tax and minority interest) of Rs 97.4 crore in the same period of previous year, Ranbaxy Laboratories said in a filing to the BSE.

Net sales of the company, however, rose to Rs 3,738 crore for the fourth quarter ended December 31, 2011, against Rs 2,086.4 crore in the same period previous year.

For the year ended December 31, 2011, the company posted a net loss of Rs 2,899.7 crore against a net profit of Rs 1,496.7 crore in 2010.

On a standalone basis, the company posted a net loss of Rs 2,710.3 crore for the fourth quarter ended December 31, 2011. It had a net profit of Rs 55.2 crore in the same period last year.

For the year ended December 31, 2011, the company posted a standalone net loss of Rs 3,052 crore, while it had a net profit of Rs 1,148.7 crore in the previous year.